Literature DB >> 27510966

Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study.

Xiaotian Liu1, Yuqian Li2, Linlin Li1, Luning Zhang1, Yongcheng Ren1, Hao Zhou1, Lingling Cui3, Zhenxing Mao1, Dongsheng Hu1,4, Chongjian Wang1.   

Abstract

The study aimed to investigate prevalence, awareness, treatment and control of type 2 diabetes mellitus (T2DM), and to explore potential risk factors in rural areas of China. A total of 16413 individuals aged 18-74 years in rural districts were recruited from the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study for the epidemiological research. Meanwhile, a meta-analysis including 7 published studies was conducted to validate the result of the cross-sectional study. The rates of crude and age-standardized prevalence, awareness, treatment and control of T2DM were 12.19%, 67.00%, 62.35%, 22.20% and 6.98%, 60.11%, 54.85%, 18.77%, respectively. The prevalence, awareness, treatment and control of T2DM displayed increased trends with age (Ptrend < 0.01) and were strongly associated with education, drinking, more vegetable and fruit intake, physical activity, family history of diabetes, body mass index (BMI). The results of this meta-analysis showed that the pooled prevalence, awareness, treatment and control of T2DM in China countryside were 7.3% (5.3-9.4%), 57.3% (36.9-77.6%), 48.4% (32.4-64.5%) and 21.0% (9.9-32.1%), respectively. The prevalence of T2DM was high with inadequate awareness, treatment and control of T2DM in China rural areas. Healthy lifestyles should be advocated to reduce prevalence and improve awareness, treatment, and control of T2DM in Chinese rural residents.

Entities:  

Mesh:

Year:  2016        PMID: 27510966      PMCID: PMC4980764          DOI: 10.1038/srep31426

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


As the third leading cause of mortality, diabetes seriously threatens to human health worldwide12, and it has caused large disease burden to the patients, their families and the society, especially in developing countries345. There are many complications of diabetes such as diabetic eye disease and diabetic nephropathy, which could lead to blindness and kidney failure567. In addition, diabetes increases the risk of cardiovascular diseases89. International Diabetes Federation (IDF) Diabetes Atlas Seventh Edition estimated that there were 415 million adults aged 20–70 living with diabetes and 5.0 million deaths were attributed to diabetes globally in 20153. Furthermore, diabetes causes huge financial burden. In 2015, 673 billion dollars were spent on health expenditure of diabetes alone, which accounted for 12% of total expenditure3. However, the prevalence of type 2 diabetes mellitus (T2DM) in almost all countries has increased rapidly in recent decades, especially in developing countries10111213. It was reported that about three quarters of people with diabetes were from low- and middle-income countries3. Epidemiological studies have confirmed that T2DM prevention and control were crucial to postpone or decrease its incidence related complications and its financial burden14. Nevertheless, the awareness, treatment and control of T2DM were disproportionately low101315. Almost half of people with this disease were undiagnosed all over the world, and the corresponding proportion was 69.83% in Chinese adults315. The prevalence of diabetes has increased from less than 1.0% in 1980 to 11.6% in 2010 in the Chinese population15, which means that more than 100 million of people were suffering from diabetes and China has become one of the largest T2DM population countries in the world. Although the prevalence is higher in cities than that in the countryside, the increase of incidence rate is faster while the awareness, treatment and control of diabetes are lower in rural districts than those in cities1617. Therefore, it is necessary to assess the epidemiological characteristics and risk factors of T2DM to take effective interventions in a specific population. Although previous studies have focused on prevalence, awareness, treatment, control and risk factors assessment in China1718, the results were inconsistent due to the difference in living regions, economy, culture, occupation, diet and life style. What’s more, the research special in synthesizing the prevalence, awareness, treatment and control of T2DM by combining rural study and meta-analysis has not yet been reported. Moreover, the meta-analysis only selected articles conducted in the Chinese countryside containing prevalence, awareness, treatment and control of T2DM. In addition, a comprehensive evaluation of T2DM epidemiology nationwide in China rural districts would potentially benefit the prevention and control of diabetes and policy-making. Therefore, the present study synthesizing prevalence, awareness, treatment and control of T2DM was conducted by combining epidemiological research and meta-analysis in China countryside areas.

Results

Demographic characteristics

Table 1 shows the demographic characteristics of the participants. Of the 16413 participants, a total of 2000 were diagnosed with T2DM. The crude and age-standardized prevalence of T2DM were 12.19% and 6.98%, respectively. Compared with those without T2DM, subjects with the disease had the following characteristics: older age, higher body mass index (BMI), higher percentage of worse marital status, lower education level, alcohol drinking, physical inactivity and family history of diabetes, lower ratios of smoking, high fat diet and more vegetable and fruit intake (P < 0.05 for each).
Table 1

Demographic characteristics.

VariableT2DM group (N = 2000)Control group (N = 14413)χ2/tP
Age (years), mean ± SD59.13 ± 8.7353.95 ± 11.50286.52<0.001
Men, n (%)702 (35.10)5273 (36.59)1.670.196
Marital status, n (%)  4.420.036
 Married/cohabiting1780 (89.40)13048 (90.86)  
 Widowed/single/divorced/separation211 (10.60)1312 (9.14)  
Education, n (%)  100.64<0.001
 ≤Primary school1110 (55.53)6280 (43.61)  
 ≥Junior school889 (44.47)8119 (56.39)  
Smoking, n (%)  16.650.001
 Never1541 (79.84)10653 (76.46)  
 Light58 (3.01)605 (4.34)  
 Moderate58 (3.01)587 (4.21)  
 Heavy273 (14.15)2087 (14.98)  
Drinking, n (%)  18.58<0.001
 Never1715 (85.75)11994 (83.22)  
 Low risk170 (8.50)1670 (11.59)  
 Medium risk57 (2.85)412 (2.86)  
 High risk58 (2.90)337 (2.34)  
More vegetable and fruit intake, n (%)358 (17.92)3203 (22.22)19.15<0.001
High fat diet, n (%)262 (13.10)2248 (15.60)8.450.004
Physical activity, n (%)  155.84<0.001
 Low998 (49.90)5276 (36.61)  
 Moderate370 (18.50)2622 (18.19)  
 High632 (31.60)6514 (45.20)  
Family history, n (%)265 (13.25)1018 (7.06)93.30<0.001
BMI (kg/m2), mean ± SD26.39 ± 3.7325.07 ± 3.554.490.034

Prevalence, awareness, treatment and control of T2DM

Table 2 presents comparison of prevalence, awareness, treatment and control of T2DM between various factors. Among subjects with T2DM, 1340 people were aware of their condition, 1247 taking medicine, and only 444 had their fasting plasma glucose (FPG) level controlled. The crude and age-standardized awareness, treatment and control of T2DM were 67.00%, 62.35%, 22.20% and 60.11%, 54.85%, 18.77%, respectively. There were increasing trends in prevalence, awareness, treatment and control of T2DM with age (P < 0.05). The prevalence displayed a decreased trend as the level of physical activity increased but an increased tendency with higher BMI. The awareness and treatment of T2DM presented tendencies toward decreasing with increasing physical activity and BMI (Table 2).
Table 2

Comparison of prevalence, awareness, treatment and control of T2DM between various factors (N = 16413).

VariablePrevalence (n = 2000)T2DM (n = 2000)
Awareness (n = 1340)Treatment (n = 1247)Control (n = 444)
Age (years), n (%)
 18~11 (1.31)2 (18.18)1 (9.09)1 (9.09)
 35~120 (5.34)55 (45.80)47 (39.17)11 (9.17)
 45~441 (9.43)267 (60.54)243 (55.10)70 (15.87)
 55~834 (16.39)579 (69.42)548 (65.71)196 (23.50)
 65~74594 (16.70)437 (73.57)408 (68.69)166 (27.95)
P<0.001<0.001<0.001<0.001
Ptrend<0.001<0.001<0.001<0.001
Gender, n (%)
 Women1298 (12.44)907 (69.88)848 (65.33)316 (24.35)
 Men702 (11.75)433 (61.68)399 (56.84)128 (18.23)
P0.196<0.001<0.0010.002
Marital status, n (%)
 Married/cohabiting1780 (12.00)1194 (67.08)1114 (62.58)390 (21.91)
 Widowed/single/divorced/separation211 (13.85)138 (65.40)126 (59.72)54 (25.59)
P0.0360.6250.4160.224
Education, n (%)
 ≤Primary school1110 (15.02)783 (70.54)730 (65.77)266 (23.96)
 ≥Junior school889 (9.87)556 (62.54)516 (58.04)178 (20.02)
P<0.001<0.001<0.0010.035
Smoking, n (%)
 Never1541 (12.64)1071 (69.50)1004 (65.15)366 (23.75)
 Light58 (8.75)35 (60.34)32 (55.17)11 (18.97)
 Moderate58 (8.99)32 (55.17)28 (48.28)7 (12.07)
 Heavy273 (11.57)160 (58.61)144 (52.75)47 (17.22)
P0.001<0.001<0.0010.020
Ptrend0.020<0.001<0.0010.005
Drinking, n (%)
 Never1715 (12.51)1189 (69.33)1112 (64.84)397 (23.15)
 Low risk170 (9.24)90 (52.94)80 (47.06)27 (15.88)
 Medium risk57 (12.15)31 (54.39)27 (47.37)8 (14.04)
 High risk58 (14.68)30 (51.72)28 (48.28)12 (20.69)
P<0.001<0.001<0.0010.069
Ptrend0.626<0.001<0.0010.101
More vegetable and fruit intake, n (%)358 (10.05)238 (66.48)220 (61.45)70 (19.55)
P<0.0010.8290.7110.180
High fat diet, n (%)262 (10.44)156 (59.54)143 (54.58)38 (14.50)
P0.0040.0060.0050.001
Physical activity, n (%)
 Low998 (15.91)701 (70.24)658 (65.93)239 (23.95)
 Moderate370 (12.37)246 (66.49)231 (62.43)80 (21.62)
 High632 (8.84)393 (62.18)358 (56.65)125 (19.78)
P<0.0010.0030.0030.137
Ptrend<0.0010.0010.0010.046
Family history, n (%)265 (20.65)211 (79.62)190 (71.70)58 (21.89)
P<0.001<0.0010.0010.895
Body mass index, n (%)
 Underweight19 (6.93)15 (78.95)14 (73.68)2 (10.53)
 Normal511 (8.55)350 (68.49)322 (63.01)111 (21.72)
 Overweight825 (12.40)564 (68.36)528 (64.00)196 (23.76)
 Obese612 (17.92)381 (62.25)354 (57.84)129 (21.08)
P<0.0010.0370.0660.368
Ptrend<0.0010.0120.0370.998

Change tendency of T2DM different subgroups

Figure 1 shows the inclination of different gender age-standardized prevalence, awareness, treatment and control of T2DM with age. The age-standardized prevalence, awareness, treatment and control of T2DM tended to increase with ageing for both genders while men had higher prevalence of T2DM than women aged younger than 55 years old, but lower at older age (Fig. 1A). The rates of awareness, treatment, and control of T2DM were all higher in women than those in men (showed in Fig. 1B–D).
Figure 1

The age-standardized prevalence (A), awareness (B), treatment (C) and control (D) of T2DM between different age groups and sex. Figure 1A is for the age-standardized prevalence of T2DM between different age groups for men and women, Fig. 1B for the age-standardized awareness of T2DM, Fig. 1C for the age-standardized treatment of T2DM, and Fig. 1D is for the age-standardized control of T2DM.

Analysis of risk factors

Table 3 describes the results of multivariate logistic regression for prevalence, awareness, treatment and control of T2DM. Compared to younger individuals, older individuals have higher prevalence, greater probability of being aware of their diabetic conditions and seeking medical treatment. Family history of diabetes was significantly related to prevalence, awareness and treatment. High risk drinking, overweight and obese were significantly positively associated with prevalence while education, more vegetable and fruit intake and higher physical activity were negatively associated with prevalence. Never drinking and high physical activity were correlated to lower levels of awareness and treatment of T2DM. No risk factors were significantly related to control of T2DM.
Table 3

Results of multivariate logistic regression for prevalence, awareness, treatment and control of T2DM.

VariablePrevalence OR95%CIT2DM
Awareness OR95%CITreatment OR95%CIControl OR95%CI
Age (years)
 18~1.001.001.001.00
 35~3.94 (2.10–7.40)3.07 (0.61–15.50)5.68 (0.69–47.09)0.81 (0.09–7.16)
 45~7.75 (4.21–14.27)5.89 (1.20–28.84)11.00 (1.36–89.03)1.44 (0.16–11.75)
 55~15.89 (8.64–29.21)8.99 (1.83–44.15)17.38 (2.15–140.89)2.32 (0.29–18.86)
 65~7415.93 (8.62–29.46)11.35 (2.29–56.29)20.42 (2.50–166.63)3.12 (0.38–25.55)
Ptrend<0.001<0.001<0.001<0.001
Gender
 Women1.001.001.001.00
 Men1.11 (0.96–1.29)0.97 (0.72–1.30)1.03 (0.77–1.37)0.81 (0.58–1.13)
Marital status
 Married/cohabiting1.001.001.001.00
 Widowed/single/divorced/separation0.94 (0.80–1.11)0.78 (0.57–1.07)0.74 (0.55–1.01)1.05 (0.75–1.48)
Education
 ≤Primary school1.001.001.001.00
 ≥Junior school0.89 (0.79–0.99)0.93 (0.74–1.17)0.98 (0.79–1.23)1.18 (0.91–1.52)
Smoking
 Never1.001.001.001.00
 Light0.88 (0.65–1.20)1.09 (0.59–2.01)1.01 (0.56–1.85)1.08 (0.51–2.27)
 Moderate0.86 (0.63–1.18)0.89 (0.48–1.65)0.84 (0.45–1.55)0.61 (0.26–1.45)
 Heavy0.85 (0.71–1.03)0.86 (0.59–1.24)0.79 (0.55–1.13)0.86 (0.55–1.35)
Ptrend<0.001<0.001<0.0010.005
Drinking
 Low risk1.001.001.001.00
 Never1.18 (0.97–1.43)1.74 (1.19–2.54)1.83 (1.26–2.66)1.27 (0.77–2.09)
 Medium risk1.15 (0.82–1.60)1.28 (0.67–2.44)1.20 (0.63–2.27)0.94 (0.37–2.34)
 High risk1.62 (1.16–2.27)1.13 (0.60–2.13)1.27 (0.68–2.40)1.93 (0.87–4.28)
Ptrend<0.0010.9200.9130.626
 More vegetable and fruit intake0.86 (0.76–0.98)1.08 (0.84–1.41)1.08 (0.84–1.40)0.91 (0.67–1.22)
 High fat diet1.04 (0.89–1.20)0.90 (0.66–1.22)0.96 (0.71–1.28)0.70 (0.48–1.03)
Physical activity
 Low1.001.001.001.00
 Moderate0.86 (0.75–0.98)0.88 (0.68–1.16)0.91 (0.70–1.18)0.95 (0.71–1.28)
 High0.61 (0.54–0.68)0.76 (0.60–0.95)0.73 (0.59–0.91)0.91 (0.71–1.18)
Ptrend<0.0010.001<0.0010.046
 Family history3.07 (2.61–3.60)2.93 (2.08–4.11)2.22 (1.63–3.02)1.22 (0.88–1.70)
Body mass index
 Normal1.001.001.001.00
 Underweight0.72 (0.44–1.16)1.68 (0.54–5.20)1.57 (0.55–4.49)0.39 (0.09–1.73)
 Overweight1.46 (1.29–1.64)1.06 (0.83–1.36)1.10 (0.86–1.40)1.22 (0.93–1.60)
 Obese2.31 (2.02–2.63)0.87 (0.67–1.13)0.71 (0.71–1.18)1.07 (0.80–1.44)
Ptrend<0.0010.0440.1200.981

Meta-analysis

According to inclusion and exclusion criteria, 7 studies15192021222324 were selected and a total of 109718 subjects containing 10260 case of diabetes were eligible for the meta-analysis (Supplementary Figure S1 and Supplementary Table S1). The pooled prevalence, awareness, treatment and control of diabetes were 7.3% (5.3–9.4%), 57.3% (36.9–77.6%), 48.4% (32.4–64.5%) and 21.0% (9.9–32.1%), respectively (Fig. 2). There was obvious heterogeneity (I > 50%), and publication bias was not found by use of the Begg’s and Egger’s tests (P > 0.05).
Figure 2

Forest plots of prevalence (A), awareness (B), treatment (C) and control (D) of diabetes of all selected studies. The pooled prevalence of T2DM in Fig. 2A, the summarized awareness of T2DM in the Fig. 2B, the pooled treatment of T2DM in Fig. 2C, and the summarized control of T2DM in Fig. 2D.

Discussion

To our knowledge, the present study is the first one attempting to overall appraise the prevalence, awareness, treatment and control of T2DM in Chinese rural population using the large sample epidemiological research and meta-analysis. The results of this epidemiological study indicated that the crude prevalence, awareness, treatment and control of T2DM were 12.19%, 67.00%, 62.35% and 22.20%, respectively, which were slightly higher than the results of this meta-analysis. In addition, the age-standardized prevalence, awareness, treatment and control of T2DM displayed increased trends with age and the rates were higher in women than those in men. The ascending trend of prevalence by age in both genders indicated incidence of T2DM in women was higher than that in men at around 50 years old, which might be because women are in the stage of menopausal transition around 50 years old. There were some differences in prevalence (12.19% vs. 7.3%), awareness (67.00% vs. 57.3%), treatment (62.35% vs. 48.4%), and control (22.20% vs. 21.0%) between both studies (epidemiological research and meta-analysis). There might be some potential reasons for the phenomenon, such as age structure and economic level of participants. The mean age of participants was 54.58 ± 11.32 years in the RuralDiab study including more older subjects (40.05% of participants aged ≥60 years old). In addition, the samples of the RuralDiab study were from four counties with higher economic level and living standard. The above reasons might have partly contributed to the higher awareness, treatment and control of T2DM in the epidemiology study31516. The further analysis showed that the age-standardized awareness (60.11%), treatment (54.85%) and control (18.77%) rates in present study were unsatisfactory compared with those in developed countries1125. Therefore, effective intervention measures should be taken to reduce the prevalence and to improve awareness, treatment and control of T2DM in Chinese rural residents. A number of studies have shown that age, poor education, family history of diabetes, physical inactivity and overweight or obese were risk factors of T2DM2627. Our study findings were in line with the reported researches. Generally speaking, enhancing education level, moderate physical activity and well controlling body weight could reduce the risk of T2DM. The relationship between alcohol consumption and T2DM remains controversial. A study from Korean demonstrated that high-risk alcohol drinking increased the risk of T2DM in men, but the association was not observed in women28. Our study found that only high-risk alcohol drinking was positively related to T2DM. Light-to-moderate alcohol drinking was confirmed to be associated with a lower risk of T2DM29. Therefore, there may be a dose-response relationship between alcohol consumption and T2DM. High fat diet and smoking are well known to be closely associated with T2DM3031. However, these associations were not found in our study. Some subjects might have changed their lifestyle after being diagnosed with T2DM, which might have influenced our results27. More vegetable and fruit intake is beneficial for the prevention of T2DM32. Similar results were found in current study. Although this is the first study combining epidemiological research and meta-analysis to synthesize the prevalence, awareness, treatment and control of T2DM in Chinese rural population, some limitations should be noted. Firstly, estimations of the prevalence, awareness, treatment and control of T2DM were based on a cross-sectional study not prospective cohort design. A meta-analysis was conducted to confirm the results of this epidemiological research. The comparable results were found in both cross-sectional study and meta-analysis. Secondly, T2DM was defined according to fasting plasma glucose level or the use of insulin or anti-diabetic medications during the previous 2 weeks or the participants’ report of previous diagnosis of diabetes by a physician and not by oral glucose tolerance test (OGTT). Given that, the prevalence of T2DM may have been misestimated. Nonetheless, fasting plasma glucose is recommended in epidemiological field studies for its convenience, cost-effectiveness and acceptability among subjects33. Thirdly, the relationship between risk factors and T2DM may be affected by confounding factors. However, adjustment of a wide range of related risk factors allowed us to control for possible confounders in this study. Fourthly, the subjects of the present study had asymmetrical age structure, and were from the districts with higher economic level and living standard, which might lead to overestimate the prevalence, awareness, treatment and control of T2DM in Chinese rural areas. Thus, the participants of the RuralDiab study need to improve and perfect in the future study. Finally, the pooled age-standardized prevalence, awareness, treatment and control of T2DM in the meta-analysis were not given due to unavailable of the age-standardized prevalence, awareness, treatment and control in many of the selected studies. Although the present study has these limitations, the results based on the synthesizing epidemiological study and meta-analysis can represent the prevalence and influence factors of T2DM in Chinese rural areas. In conclusion, the prevalence of T2DM is high, but the proportions of awareness, treatment and control are relatively low in China rural districts, which are slightly higher than the results of meta-analysis. Women have larger proportions of prevalence, awareness, treatment and control of T2DM than men. The prevalence of T2DM is significantly and positively associated with age, high risk alcohol drinking, being overweight or obese and having a family history of diabetes and negatively associated with higher education level, more vegetable and fruit intake and higher physical activity. Therefore, attention should be paid to healthy lifestyles to reduce the prevalence and improve awareness, treatment and control of T2DM in Chinese rural residents.

Methods

Study subjects

The subjects were from the Rural Diabetes, Obesity and Lifestyle (RuralDiab) study which was conducted in Yuzhou county in Xuchang city, Wuzhi county in Jiaozuo city, Houzhai village in Zhengzhou City and Xinan county in Luoyang city of Henan Province in China from July 2013 to August 2015. A total of 18817 participants completed the survey and physical examination from rural areas. To evaluate prevalence, awareness, treatment and control of T2DM of adults in rural areas, study subjects were excluded if they: (1) had type 1 diabetes mellitus (n = 8); (2) were aged <18 years or aged >74 years (n = 1311); and (3) did not have information about whether they were diagnosed diabetes: (n = 1085). Finally, 16413 subjects were included for the present study. This study was approved by the Zhengzhou University Ethics Committee. Informed consent was signed by all study participants or their agents. The present study was conducted according to the Declaration of Helsinki.

Data collection and laboratory methods

Data were collected by face to face investigation. A standard questionnaire including information on general demographic characteristics (name, gender, living region, age, education level, marital status, occupation, family economic, medical services received, etc), life styles (intakes of vegetable, fruit, fat and protein intake, smoking, alcohol drinking, physical activity etc.), the personal history of diseases (hypertension, dyslipidemia, diabetes, coronary heart disease, stroke, etc), family history of diseases (hypertension, dyslipidemia, diabetes, coronary heart disease, stroke, etc) was completed by well-trained investigators. Anthropometric measurements (height, weight, waist circumference, hip circumference and blood pressure) were performed. Height and body weight were measured with the subjects in light clothing and shoes off. Waist circumference at the level of 1.0 cm above the navel and hip circumference at the maximal level of the hip were measured with light clothing. After at least 8 hours of overnight fasting, the fasting venous blood samples were collected for the measurement of plasma glucose. Blood samples were stored in −80 °C cryogenic refrigerator. FPG was measured by ROCHE Cobas C501 automatic biochemical analyzer with glucose oxidative method (GOD-PAP).

Assessment of outcomes

T2DM was defined according to the American Diabetes Association (ADA) 200934: FPG ≥7.0 mmol/L or self-reported use of insulin or anti-diabetic medications during the previous 2 weeks or participants reported he/she had previous diagnosis of diabetes by a physician. Awareness of those with T2DM was considered if they reported having a previous diagnosis of diabetes by physicians. The application of hypoglycemic medicine either insulin or oral pills during the previous 2 weeks was defined as treatment of those with T2DM. Individuals with T2DM were considered to have controlled plasma glucose if FPG ≤7.0mmol/L.

Assessment of covariate factors

Education levels were classified as: ≤primary school (including those who never attended school, and those who attained primary school only); ≥junior school (including those who attained junior school or higher levels of education). In accordance with the smoking index (SI, SI = lifetime smoking intensity × duration of smoking) of the World Health Organization (WHO 1997), smoking was categorized into heavy smoking (SI ≥ 400), moderate smoking (200 ≤ SI < 400), light smoking (0 < SI < 200) and never smoking. Based on the daily intake amount of alcohol of China Public Union of Nutrition35 and WHO36 drinker was classified into never drinking, low risk drinking (0< ethanol/day ≤15g for women, 0< ethanol/day ≤25g for men), medium risk drinking (15< ethanol/day ≤40g for women, 25< ethanol/day l ≤ 60g for men), high risk drinking (ethanol/day >40g for women, ethanol/day >60g for men). More vegetable and fruit intake (adequate vegetable and fruit intake) was considered as a person who took more than 500g vegetable and fruit per day, and high fat diet was defined as a person who takes an average of more than 75g meat of livestock and poultry per day in line with the dietary guidelines for Chinese residents35. According to the international physical activity questionnaire (IPAQ 2001), physical activity was classified into low, moderate and high. BMI was divided into four levels: low weight, BMI <18.5 kg/m2; normal weight, 18.5≤ BMI <24 kg/m2; overweight, 24≤ BMI <28 kg/m2; and obese, BMI ≥28 kg/m2.

Data extraction of meta-analysis

A meta-analysis was performed according to the guidelines of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)37. Relevant studies in Web of Science, PubMed, CNKI (Chinese) and Wanfang (Chinese) databases surveyed from 1 January 2010 to 20 June 2016 (date of publication) were included by using the search terms ‘prevalence’, ‘awareness’, ‘treatment’, ‘control’, ‘type 2 diabetes mellitus or diabetes’, ‘China or Chinese’, ‘rural or countryside’ and these terms’ derivation and combinations. All pooled studies required to meet the following inclusion criteria: (1) the participants of studies were Chinese people (including Hong Kong, Macao and Taiwan); (2) the study had to report the number of total sample, prevalence, awareness, treatment and control of T2DM or diabetes of rural districts at the same time; and (3) based on population samples rather than volunteers. Exclusion criteria were: (1) reviews, editorials, commentaries, or reports etc; (2) duplication of studies, that is, repeating data that were already reported by other included articles ; and (3) studies focusing on special population, such as occupational crowds, health check-up population, ethnicity, or age groups. Two investigators independently extracted data information. Controversies were solved by discussion with necessity. For all selected studies, we extracted information regarding the first author, year of publication, study location, year of survey, age range, sampling method, diagnostic criteria, diagnosis method, total sample size (male/female), number of diabetes (male/female), prevalence (male/female), awareness (male/female), treatment (male/female), and control (male/female) of diabetes in rural districts.

Statistical Analysis

All survey data were analyzed using SAS9.1 software package (SAS Institute, USA) and α = 0.05 was considered as significant difference. Descriptive statistics was used to summarize participants’ characteristics. Student t-test and chi-square test were applied to compare continuous and categorical variables, respectively. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to explore the association between the socio-demographic factors and the prevalence, awareness, treatment and control of T2DM. All selected characteristics were included in multivariable logistic regression models. Direct standardized methods using the Population Census 2010 were utilized to estimate age-standardized prevalence, awareness, treatment and control of T2DM. The meta-analysis was performed using the Stata Software Package, V11.0 (StataCorp, College Station, Texas, USA). Pooled estimates of diabetic prevalence, awareness rate, treatment rate, and control rate and their corresponding 95% confidence intervals (CIs) were calculated based on the random effect model. Statistical heterogeneity was evaluated by the Istatistic (low, I < 25%; moderate, 25–50%; high, I > 50%)38. To explore potential publication bias, the Begg’s and Egger’s tests were conducted.

Additional Information

How to cite this article: Liu, X. et al. Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study. Sci. Rep. 6, 31426; doi: 10.1038/srep31426 (2016).
  31 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

Authors:  Juliana C N Chan; Vasanti Malik; Weiping Jia; Takashi Kadowaki; Chittaranjan S Yajnik; Kun-Ho Yoon; Frank B Hu
Journal:  JAMA       Date:  2009-05-27       Impact factor: 56.272

Review 3.  Chronic kidney disease.

Authors:  Andrew S Levey; Josef Coresh
Journal:  Lancet       Date:  2011-08-15       Impact factor: 79.321

4.  Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group.

Authors:  X R Pan; W Y Yang; G W Li; J Liu
Journal:  Diabetes Care       Date:  1997-11       Impact factor: 19.112

Review 5.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.

Authors:  Goodarz Danaei; Carlene M M Lawes; Stephen Vander Hoorn; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

Review 6.  Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis.

Authors:  An Pan; Yeli Wang; Mohammad Talaei; Frank B Hu; Tangchun Wu
Journal:  Lancet Diabetes Endocrinol       Date:  2015-09-18       Impact factor: 32.069

7.  Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study.

Authors:  Dongsheng Hu; Liang Sun; Pengyu Fu; Jing Xie; Jie Lu; Jing Zhou; Dahai Yu; Paul K Whelton; Jiang He; Dongfeng Gu
Journal:  Diabetes Res Clin Pract       Date:  2009-06       Impact factor: 5.602

8.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.

Authors:  Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

9.  Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study.

Authors:  Dongsheng Hu; Pengyu Fu; Jing Xie; Chung-Shiuan Chen; Dahai Yu; Paul K Whelton; Jiang He; Dongfeng Gu
Journal:  Diabetes Res Clin Pract       Date:  2008-05-20       Impact factor: 5.602

10.  Prevalence and awareness of diabetes mellitus among a rural population in China: results from Liaoning Province.

Authors:  X Zhou; H Guan; L Zheng; Z Li; X Guo; H Yang; S Yu; G Sun; W Li; W Hu; L Guo; G Pan; L Xing; Y Zhang; Y Sun
Journal:  Diabet Med       Date:  2014-12-16       Impact factor: 4.359

View more
  34 in total

1.  Sleep Duration Interacts With Lifestyle Risk Factors and Health Status to Alter Risk of All-Cause Mortality: The Rural Chinese Cohort Study.

Authors:  Feiyan Liu; Hongyan Zhang; Yu Liu; Xizhuo Sun; Zhaoxia Yin; Honghui Li; Kunpeng Deng; Yang Zhao; Bingyuan Wang; Yongcheng Ren; Lu Zhang; Junmei Zhou; Chengyi Han; Xuejiao Liu; Dongdong Zhang; Guozhen Chen; Shihao Hong; Chongjian Wang; Dongsheng Hu; Ming Zhang
Journal:  J Clin Sleep Med       Date:  2018-05-15       Impact factor: 4.062

2.  Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population.

Authors:  Qing Liu; Fang Li; Yaqiong Yan; Tingting Wu; Miao Zhang; Changfeng Li
Journal:  BMC Public Health       Date:  2022-07-19       Impact factor: 4.135

3.  Predictive significance of joint plasma fibrinogen and urinary alpha-1 microglobulin-creatinine ratio in patients with diabetic kidney disease.

Authors:  Lianlian Pan; Mingyi Wo; Chan Xu; Yan Wu; Yali Ye; Fan Han; Xianming Fei; Fengjiao Zhu
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Investigating the predictive power of constructs of extended Pender's health promotion model and some background factors in fruit and vegetable consumption behavior among government employees.

Authors:  Freshteh Khatti-Dizabadi; Jamshid Yazdani-Charati; Reza Amani; Firoozeh Mostafavi
Journal:  J Educ Health Promot       Date:  2022-03-23

5.  Thyroid stimulating hormone and free triiodothyronine are valuable predictors for diabetic nephropathy in patient with type 2 diabetes mellitus.

Authors:  Xianming Fei; Mingfen Xing; Mingyi Wo; Huan Wang; Wufeng Yuan; Qinghua Huang
Journal:  Ann Transl Med       Date:  2018-08

6.  Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study.

Authors:  Xiaolei Han; Ziying Jiang; Yuanjing Li; Yongxiang Wang; Yajun Liang; Yi Dong; Shi Tang; Yifeng Du; Chengxuan Qiu
Journal:  BMC Geriatr       Date:  2021-03-04       Impact factor: 3.921

7.  Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013.

Authors:  Jing Wu; Hongqin Xu; Xiuting He; Yi Yuan; Chunyan Wang; Jie Sun; Shumei He; Junqi Niu
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

8.  Prevalence, Awareness and Associated Risk Factors of Diabetes among Adults in Xi'an, China.

Authors:  Meiqin Hu; Yi Wan; Lifen Yu; Jing Yuan; Yonghong Ma; Bin Hou; Xun Jiang; Lei Shang
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

9.  Independent and cumulative effects of resting heart rate and pulse pressure with type 2 diabetes mellitus in Chinese rural population.

Authors:  Panpan Wang; Yuqian Li; Xiaotian Liu; Quanxin Wang; Ying Guo; Yang Zhao; Linlin Li; Jingjing Fan; Hao Zhou; Zhenxing Mao; Gongyuan Zhang; Chongjian Wang
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

10.  Diabetes in Shenzhen, China: epidemiological investigation and health care challenges.

Authors:  Xinfeng Yan; Hui Xia; Haitao Li; Xiaoting Deng; Lizhen Yang; Shaojuan Zhao; Jianfeng Zou; Yi Luo; Sijing Cao
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.